Nanofibre platform shows potential for inhibiting brain tumour growth
Scientists have created a nanofibre-based sheet to control and direct the migration of cells, possibly leading to brain tumour therapies.
List view / Grid view
Scientists have created a nanofibre-based sheet to control and direct the migration of cells, possibly leading to brain tumour therapies.
According to researchers, Rab27b and epiregulin contribute to the development of radioresistance and could be targeted to improve glioblastoma patient survival.
Lab-grown brain organoids from patients’ glioblastomas could be useful models to rapidly test and identify effective personalised treatments, find researchers.
A new study has shown that an experimental drug known as AZ32 significantly extends the survival of glioblastoma multiforme, the most common and deadly form of brain cancer...
The research, using tumour cells in the laboratory and in mice, will see if the Zika virus can destroy cancer cells.
The loss of the tumour suppressor gene PTEN has been linked to tumour growth and chemotherapy resistance in the almost invariably lethal brain cancer glioblastoma multiforme (GBM).
The outlook for brain tumour patients is pretty negative, with the median survival rate for patients with glioblastoma multiforme, or GBM, a mere 14.2 months.
18 August 2016 | By Niamh Louise Marriott, Digital Content Producer
A deep-water marine sponge collected at Fort Lauderdale's coast contains leiodermatolide, a natural product that inhibits the growth of cancer cells as...
9 June 2016 | By Victoria White, Digital Content Producer
A new method, developed by UCLA scientists, could eventually lead to a way to improve accuracy of how well a patient will respond to treatment...
9 June 2016 | By Victoria White, Digital Content Producer
ReNeuron selected glioblastoma multiforme based on evidence of tumour-inhibiting activity from early preclinical studies with the exosome technology...
2 June 2016 | By Victoria White, Digital Content Producer
Researchers have initiated a new preclinical study aimed at developing a vaccine for the treatment of glioblastoma multiforme using ImmunoBody technology...
25 May 2016 | By Victoria White, Digital Content Producer
The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...
9 May 2016 | By Victoria White, Digital Content Producer
In laboratory tests on human cells and mouse models, an experimental therapy was shown to stop treatment-resistant glioblastoma and high-grade gliomas...
Brain tumours are complex cancer types, arising in many unique forms, each having varying survival rates and differing methods of treatment. Many brain tumours are difficult to clearly diagnose, leading to poor patient prognoses. Although they are mainly diagnosed by analysing morphological appearance, this does not closely correlate with the…
13 November 2015 | By Victoria White
PPF works to limit the spread of glioblastoma multiforme by targeting a protein called TROY...